Ratings
0
Nobody has rated this yet. Be the first!
Works
2
Treatment of HER2-positive breast cancer: current status and future perspectives.
PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance).